Shimadzu (7701 JP): Conservative Guidance
Down 13.5% from its recent high despite beating guidance for last FY and low-balling this FY. Healthcare and semiconductor demand remain strong....
303 Views
Shimadzu (7701 JP): Buy into the Sell-Off
The shares have dropped 14% from an all-time high reached on Feb 22, while sales have recovered from the COVID downturn and profit margins are...
332 Views
Shimadzu (7701 JP): Virus Defeated in 1Q
After guiding for a 12% decline in sales and a 47% decline in operating profit in FY Mar-21 as a whole, Shimadzu delivered a 1% year-on-year...
362 Views
Terumo: Not Just an Opportune COVID Play but a Business with Solid Long-Term Prospects
Terumo Corp (4543 JP) provides innovative medical solutions through its extensive business portfolio which ranges from vascular intervention and...
464 Views
Shimadzu (7701 JP): New Guidance at Risk, Valuations Not Compelling
Shimadzu has lowered sales and profit guidance for FY Mar-20, but perhaps not by enough considering 3Q results and the impact of the...
435 Views